At the pan-cancer level, most signaling pathways, particularly PKP4, PKP2, JUP, and CTNND2, showed high levels of activation in the Hormone AR signaling pathway, but consistent inhibition of apoptosis, cell cycle, and DNA damage responses (Fig. 1C). The gene discussed is PKP2; the disease is cancer.